Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4192882 Title: TRAITEMENT DE LA NÉPHROPATHIE LUPIQUE AVEC ANIFROLUMAB ANTICORPS DU RÉCEPTEUR INF ANTI-TYPE I

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
227247129
WO application number:
EP2022060670
Type:
European patent granted for BE
Status:
Open
Publication number:
4192882
WO publication number:
WO2022223771
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
22/04/2022
Grant date:
19/02/2025
EP publication date:
14/06/2023
WO publication date:
27/10/2022
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/02/2025
EP B1 publication date:
19/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
22/04/2042

Applicant

Name:
Astrazeneca AB
Legal Form:
From:
19/02/2025
Address:
151 85 Södertälje, Sweden (SE)
To:

Agent

Name:
NOVAGRAAF BREVETS
Legal Form:
From:
04/03/2025
Address:
Bâtiment O2 2 rue Sarah Bernhardt CS90017, 92665, Asnières-sur-Seine Cedex, France (FR)
To:

Inventor

1

Name:
LINDHOLM, Catharina
Legal Form:
Address:
151 85 Södertälje, Sweden (SE)

2

Name:
CHIA, Yen Lin
Legal Form:
Address:
Wilmington, Delaware 19850-5437, United States (US)

3

Name:
TUMMALA, Rajendra
Legal Form:
Address:
Wilmington, Delaware 19850-5437, United States (US)

4

Name:
ROSKOS, Lorin
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

5

Name:
ALMQUIST, Joachim
Legal Form:
Address:
151 85 Södertälje, Sweden (SE)

6

Name:
ROUSE, Tomas
Legal Form:
Address:
151 85 Södertälje, Sweden (SE)

7

Name:
TRASIEVA, Teodora
Legal Form:
Address:
151 85 Södertälje, Sweden (SE)

8

Name:
WHITE, Wendy
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

9

Name:
SINIBALDI, Dominic
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

10

Name:
RAMASWAMY, Madhu
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

11

Name:
NEWCOMBE, Paul
Legal Form:
Address:
Cambridge Cambridgeshire CB2 0AA, United Kingdom (GB)

Priority

1

Priority patent number:
202163270091 P
Priority date:
21/10/2021
Priority country:
United States (US)

2

Priority patent number:
202163221986 P
Priority date:
15/07/2021
Priority country:
United States (US)

3

Priority patent number:
202163178745 P
Priority date:
23/04/2021
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/28; A61P 29/00; G01N 33/53; A61M 5/00;

Publication

European Patent Bulletin

1

Issue number:
202508
Publication date:
19/02/2025
Description:
Grant (B1)

2

Issue number:
202513
Publication date:
26/03/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
30/04/2026
Annual fee number:
5
Annual fee amount:
75 Euro
Expected payer:
Last annual fee payment date:
11/03/2025
Last annual fee paid number:
4
Last annual fee paid amount:
55 Euro
Payer:
RENEWALSDESK LIMITED
Filing date Document type Publication Type Document Description Number of pages File Type
04/03/2025 Incoming Correspondence (Post) 1 PDF /3/6/7/1/1/0722511763/docs/227247129_0_incomingcorrespondencepaper_20250305_020622503.pdf